We investigated imaging conditions for the distribution of lutetium oxodotreotide (Lu-177 DOTATATE) in the body during peptide receptor radionuclide therapy for neuroendocrine tumor (NET). We investigated imaging conditions using gamma rays emitted from the radionuclide. The gamma rays had energy peaks at 113 and 208 keV and characteristic X-rays at 56 keV. Image quality was compared by utilizing a combination of low–medium-energy general-purpose (LMEGP) and medium-energy general-purpose (MEGP) collimators. This study included the measurement of total spatial resolution (Full Width at Half Maximum) using a line source phantom. We compared the image quality of static images using a plane phantom and SPECT images using a cylindrical phantom. This comparison involved assessing recovery coefficient curves, count ratio, and %CV. Imaging evaluation was also performed on one NET patient. In phantom studies and the clinical study, comparing the combination of the three energy peaks (56 + 113 + 208 keV) using the LMEGP collimator and the conventional combination (113 + 208 keV) using the MEGP collimator revealed a count ratio of 1.9 times the maximum, stable %CV, and the best image quality.
3 September 2020 in Journal of Nuclear Medicine Technology
Purpose: The number of patients with the extremely rare disease GEP-NET (gastroenteropancreatic neuroendocrine tumor) has increased rapidly in recent years. In-111-pentetreotide single photon emission computed tomography (111In-pentetreotide SPECT) in somatostatin receptor scintigraphy (SRS) has been used for the assessment of GEP-NET patients. To diagnose GEP-NET, appropriate selection of the image correction parameters is of critical importance. Correction methods may improve the 111In-pentetreotide SPECT image quality, but there is currently no standard technique. The purpose of this study was to determine the optimal correction parameter settings for 111In-pentetreotide SPECT imaging. Materials and Methods: A phantom study produced scan images with a tumor-to-background ratio as high as 16:1. Triple energy window was used for scatter correction (SC), and computed tomography-based attenuation correction was used for attenuation correction (AC). Correlation analysis was performed in four groups: no correction (NC), SC, AC, and combined SC with AC corrections (CC). 111In-pentetreotide SPECT results of twenty patients (13 men and 7 women; age range, 37-81 years) randomly selected patients with confirmed GEP-NET were analyzed, using data collected four hours after injection of 111 MBq 111In-pentetreotide. Emission data were reconstructed using ordered subset expectation maximization (OSEM) reconstruction, with different settings. Different combinations of the correction parameters were used to analyze the contrast to noise ratios (CNR) obtained with the phantom. In the clinical study, 20 GEP-NET patients evaluated the GEP-NET lesion CNR by four different image correction methods obtained from 111In-pentetreotide SPECT images: 1) NC, 2) SC, 3) AC, and 4) CC. NC was employed as a reference method. Results: The phantom study revealed that the optimal energy window in the photopeak for SRS was 171 keV ± 10% and 245 keV ± 7.5%, and the optimal OSEM reconstruction conditions were 8 subsets and 6 iterations. Among the OSEM collection conditions, CC produced a significantly higher CNR than NC or SC (p<0.05). In the clinical study, CC was found to increase the CNR (p<0.05). Conclusion: CC improves the correction in 111In-pentetreotide SPECT studies, compared with NC, providing better contrast and sharper outlines of lesions and organs.
12 December 2019 in Radiological Physics and Technology
Background: There is no phantom for image quality test in magnetic resonance imaging combined with positron emission tomography systems (PET/MRI systems). In MRI, radioactive water phantom containing 2-deoxy-2-[F-18] fluoro-D-glucose (18F-FDG) cannot be used due to the dielectric effect. Even for phantoms filled with MR-available solutions, the source current of the RF coil is strongly disturbed as the diameter of the phantom increases. Stable MR images require proper phantom size and solution selection. Previous reports have not provided these details. Other than that, few existing phantoms evaluate negative signals such as N-13 ammonia (13N-NH3). We created a phantom for PET/MRI system for image quality test. Methods: The phantom for the PET/MRI system was assembled in two portions. One portion is a signal part containing 18F-FDG radioactive water. The other portion is filled with polyvinyl alcohol glue to construct MRI image to generate μ-map. The glue part is allowed to rewrite the table position overlaps with the first layer, and attenuation correction is performed. Signals are set as positive (4 times and twice higher than background radioactivity) and negative (no radioactivity) columns with different sizes (15 mm φ and 7 mm φ). The PET images with CT-AC and MRI-AC were evaluated by %-contrasts, variation and uniformity. Results: The %-contrasts of the positive shallow signals with PET/MR and PET/CT were 41.8% and 45.4%, respectively. And it of the positive deep signals with PET/MR and PET/CT were 40.7% and 44.9%. On the other hand, the %-contrasts of the negative shallow signals with PET/MR and PET/CT were 62.3% and 65.6%, respectively. And it of the negative deep signals with PET/MR and PET/CT were 60.7% and 63.7%. Moreover, the% Nj index of uniformity was 2.0% on PET / MRI images and 0.34% on PET / CT images. For negative signals that assume a decrease in myocardial blood flow, The image quality of MR-AC was almost the same as that of CT-AC. Consistency between the images after CT-AC and MR-AC correction were confirmed, and in particular, a stable MR-AC μ-map was obtained in the phantom study. Conclusion: The suggested prototype phantom for generating μ-map is reasonable and useful for evaluating PET/MRI image quality, based on the present standard.
The image quality index for whole-body bone scintigraphy has traditionally relied on the total count (Total-C) with a threshold of ≥1.5 million counts (MC). However, Total-C measurements are susceptible to variability owing to urine retention. This study aimed to develop a skeletal count (Skel-C)-based index, focusing exclusively on bone regions, to improve the accuracy of image analysis in bone scintigraphy. To determine the optimal Skel-C-based threshold, Skel-C thresholds were set at 0.9, 1.0, 1.1, and 1.2 MC, and Total-C thresholds were set at 1.75, 2.0, and 2.25 MC. Patients were then categorized based on whether their values were above or below these thresholds. The group including all cases was defined as the Total-C 1.5 high group. Sensitivity and specificity were calculated for each group, and receiver operating characteristic analyses and statistical evaluations were conducted. The specificity of the bone scintigraphy image analysis program in the Skel-C < 0.9 MC group was significantly lower than that in the Skel-C ≥ 0.9 MC and Total-C 1.5 high groups. The decrease in specificity was evident only with Skel-C and was not identified based on Total-C levels. These findings highlight the importance of achieving Skel-C ≥ 0.9 MC and suggest that Total-C alone is insufficient for reliable image assessment.
We compared scatter correction (SC) in single-photon emission computed tomography (SPECT) images using effective scatter source estimation (ESSE) and the triple-energy window (TEW) method. We acquired 99mTc and 123I images of brain, myocardial, and performance phantoms containing rods with different diameters. We assessed contrast ratios (CRs) and ROI-based noise metrics (coefficient of variation, signal-to-noise ratio, and contrast-to-noise ratio [CNR] ). Under 99mTc, ESSE yielded higher CRs than TEW across all phantoms (mean difference 0.04, range 0.01–0.05) and produced the highest CNR in the myocardial phantom, improving the conspicuousness of the simulated defect. Under 123I, CR differences between ESSE and TEW were small and inconsistent (performance phantom: −0.04 to 0.06; brain phantom: −0.01 to 0.00). A Monte Carlo simulation (point source in air) showed substantial photopeak window penetration for cardiac high-resolution collimators (40.0%) but low penetration for medium-energy general-purpose collimators (5.1%), supporting photopeak contamination as a contributor to the 123I findings and potentially attenuating the apparent advantage of model-based SC that does not explicitly account for penetration photons. These findings suggest that SC selection should consider the radionuclide and imaging target and that ESSE might be a reasonable option for 99mTc myocardial imaging under the settings examined.